S
Sichuan Zhishan Weixin Biotechnology
A company working in the field of gene therapy
At a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 20.8/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Feb 2023 | $28M | $165M | Pan-Lin Asset Management · SDIC Venture Capital · Essence Capital · Loyal Valley Capital | ↗ |
| SPINOUT✓Other financing | Jun 2018 | $0 | — | Sichuan University | — |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Sichuan Zhishan Weixin Biotechnology in its local ecosystem
The Sichuan Zhishan Weixin Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Pan-Lin Asset Management
SDIC Venture Capital- ECEssence Capital
Loyal Valley Capital
Other known investors1 additional known investor
Sichuan University
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sichuan Zhishan Weixin Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sichuan Zhishan Weixin Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









